Gossamer Bio, Inc.
GOSSNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $38.88M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.15$21.46
- Volume (live)
- -
- Avg. volume (3M)
- 301.95K
Gossamer Bio (GOSS) Stock Price & Financial Analysis
Gossamer Bio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $9.34 - $9.97 |
|---|---|
| 52-Week High | $21.46 |
| 52-Week Low | $0.15 |
| Open | $9.73 |
| Volume (last close) | 188.77K |
| Average Volume (3M) | 301.95K |
| Revenue (TTM) | 53.29M |
|---|---|
| Net Income (TTM) | -125.22M |
| Free Cash Flow (TTM) | -162.63M |
| EPS (TTM) | −$39.38 |
| Profit Margin | -235.00% |
| Operating Margin | -297.67% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 38.88M |
|---|---|
| Shares Outstanding | 4.11M |
| Price to Sales (P/S) | 0.73 |
| Price to Book (P/B) | -0.41 |
| EV/EBITDA | -0.32 |
| 50-Day MA | $11.72 |
|---|---|
| 200-Day MA | $6.31 |
| 1-Year Change | +352.63% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Gossamer Bio at a Glance
As of the Oct 22, 2026 close, Gossamer Bio (GOSS) has a market capitalization of $38.88M. The stock trades at 0.7× sales. Over the trailing twelve months it lost $125.22M on revenue of $53.29M and burned $162.63M of free cash flow. Revenue grew 32.4% year over year.
As of its latest reported balance sheet, it holds $41.15M in cash and securities against $39.10M of debt, a net cash position of $2.04M.
Gossamer Bio does not currently pay a dividend.
The share price is up 352.6% over the past year. At $9.46 (the Oct 22, 2026 close) it sits within its 52-week range of $0.15 to $21.46, above its 200-day moving average of $6.31.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $68.10, 619.9% above the Oct 22, 2026 close.
Frequently Asked Questions About Gossamer Bio
What is the current stock price for GOSS?
As of the Oct 22, 2026 close, GOSS stock trades at $9.46. The 52-week range is $0.15–$21.46, with a day range of $9.34–$9.97.
What is the P/E ratio for GOSS?
The P/E ratio (Price-to-Earnings) for GOSS is shown in the Key Statistics section. This valuation metric helps compare Gossamer Bio, Inc. to industry peers.
Does GOSS pay dividends?
Gossamer Bio does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for GOSS?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for GOSS is Hold. The average 12-month price target is $68.10, a 619.9% upside from the Oct 22, 2026 close of $9.46.
What is the market cap of GOSS?
As of the Oct 22, 2026 close, Gossamer Bio's market capitalization is $38.9M, classifying it as a micro-cap company. Gossamer Bio operates in the Healthcare sector within the Biotechnology industry.